Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations:
Systematic head & neurological exam:
Systematic examination:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (large head / vomiting / lethargy / developmental delay). On examination, the child appears _____ (well/unwell), with _____ (head size / shape). Head circumference: _____ cm (_____ percentile). Parental OFC: _____ cm. Fontanelle: _____ (open/closed, tense/bulging). Sutures: _____ (separated/closed). Eye findings: setting‑sun sign _____ (present/absent), fundi _____ (normal / papilledema / optic atrophy). Neurological exam: tone _____ (increased / decreased), reflexes _____ (brisk / normal), plantars _____ (flexor / extensor). Growth: weight _____ percentile, height _____ percentile. Associated signs: _____ (midline back defect, neurocutaneous stigmata, VP shunt).
• Communicating hydrocephalus – impaired CSF absorption (post‑meningitis, SAH).
• Non‑communicating (obstructive) – aqueduct stenosis, posterior fossa tumour, Chiari.
• Congenital – aqueduct stenosis, Dandy‑Walker, Chiari II.
• Acquired – post‑meningitis, post‑haemorrhage, tumour.
• Familial macrocephaly – benign, normal development.
• Megalencephaly – Sotos, NF, metabolic (Canavan, Alexander).
• Subdural collections – haematoma, effusion (often after trauma).
• Benign extra‑axial fluid of infancy – resolves by 2 years.
• Vein of Galen malformation – bruit, heart failure.
• Hydranencephaly – absent cerebral hemispheres.
• Head ultrasound – if fontanelle open (ventricular size, haemorrhage).
• Brain MRI / CT – ventricular dilation, cause (tumour, aqueduct stenosis, Chiari).
• CSF flow studies – MRI CINE (to assess obstruction).
• ICP monitoring – if diagnosis uncertain.
• MRI brain – structural cause (tumour, Chiari, Dandy‑Walker).
• Toxoplasmosis / CMV – congenital infection.
• Genetic testing – if syndromic (L1CAM, etc.).
• LP – if infection (after imaging).
• Ophthalmology – papilledema, fundoscopy.
• CT / MRI – to differentiate from megalencephaly, subdural.
• EEG – if seizures.
• Metabolic screen – if neurodegenerative.
• Skeletal survey – if skeletal dysplasia.
• TORCH screen – if congenital infection.
• Ophthalmology – visual fields, optic atrophy (raised ICP).
• Shunt series – if VP shunt (malfunction: X‑ray, CT, nuclear medicine shunt patency).
• Psychometric assessment – cognitive function.
• Feeding / swallow – if bulbar involvement (Chiari).
• Endocrine – if hypothalamic involvement (growth hormone, puberty).
🔹 Management – Across Organ Systems
VP shunt (ventriculoperitoneal), VA shunt, ETV (endoscopic third ventriculostomy).
Head elevation, mannitol, hyperventilation (if imminent herniation), emergency shunt.
Acetazolamide (temporary), furosemide (to reduce CSF production – limited role).
Seizure management (if present), spasticity management (baclofen, physiotherapy).
Early intervention, physiotherapy, OT, speech therapy, special education.
Regular monitoring for papilledema, optic atrophy, visual fields.
Shunt infection: IV antibiotics, shunt removal/externalisation, then replacement.
Neurosurgery, neurology, developmental paediatrics, ophthalmology, rehabilitation.
📈 Prognosis
📋 Follow‑up Schedule